Characteristics of Streptococcus Pseudopneumoniae Isolated from Purulent Sputum Samples
Overview
Affiliations
Streptococcus pseudopneumoniae is a recently described streptococcus that is phenotypically and genetically distinct from Streptococcus pneumoniae and other viridans streptococci. Key characteristics of S. pseudopneumoniae are the absence of a pneumococcal capsule, insolubility in bile, resistance or indeterminate susceptibility to optochin when incubated in 5% CO2 but susceptibility to optochin when incubated in ambient air, and a positive reaction with the AccuProbe DNA probe hybridization test. The clinical importance of this bacterium is currently unknown. We report the characteristics and associated clinical data of 35 strains of S. pseudopneumoniae isolated from sputum samples from 33 patients. All isolates produced a positive result with the NOW S. pneumoniae antigen test (Binax, Inc.). No isolate was resistant to penicillin, but 60% were resistant to erythromycin and 77% were resistant to tetracycline. All patients had lower respiratory tract symptoms, 79% had chronic obstructive pulmonary disease (COPD), and 33% had chest radiographic infiltrates. Compared with matched control patients who had Streptococcus pneumoniae isolated from sputum, patients with S. pseudopneumoniae infection were more likely to have a history of COPD (odds ratio [OR], 5.0; 95% confidence interval [CI], 1.67 to 20.11) or exacerbation of COPD (OR, 6.5; 95% CI, 2.61 to 16.20). Further research is needed to better characterize the epidemiology of S. pseudopneumoniae colonization and the role of S. pseudopneumoniae in COPD and other diseases.
A novel LAMP-based assay for the identification of and in clinical isolates.
Basheer M, Sasic K, Carlsson A, Vestberg N, Henriques-Normark B, Blomqvist K J Clin Microbiol. 2024; 62(12):e0091224.
PMID: 39526793 PMC: 11633111. DOI: 10.1128/jcm.00912-24.
Pulmonary abscess caused by in a child: A case report and review of literature.
Ma R, Wang Y, Guan H, Zhang L, Zhang W, Chen L World J Radiol. 2024; 16(8):362-370.
PMID: 39239243 PMC: 11372553. DOI: 10.4329/wjr.v16.i8.362.
as an emerging respiratory tract pathogen at Assiut University hospitals.
Sayed Z, Abdel-Ghany M, Ahmed S, Adawy A, El-Hamid R Iran J Microbiol. 2022; 14(5):645-652.
PMID: 36531811 PMC: 9723435. DOI: 10.18502/ijm.v14i5.10957.
Tabata A, Matsumoto A, Fujimoto A, Ohkura K, Ikeda T, Oda H J Oral Microbiol. 2022; 14(1):2105013.
PMID: 35937899 PMC: 9351568. DOI: 10.1080/20002297.2022.2105013.
Competitive advantage of oral streptococci for colonization of the middle ear mucosa.
Jacob K, Reguera G Biofilm. 2022; 4:100067.
PMID: 35146417 PMC: 8818537. DOI: 10.1016/j.bioflm.2022.100067.